Strengths

● The stock, which is currently worth 2017 to 0.57 times its sales, is clearly overvalued in comparison with peers.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● The stock is in a well-established, long-term rising trend above the technical support level at 7.15 USD


Weaknesses

● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.

● Technically, the stock approaches a strong medium-term resistance at USD 10.52.

● The group shows a rather high level of debt in proportion to its EBITDA.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The group usually releases earnings worse than estimated.

● For the past year, analysts have significantly revised downwards their profit estimates.